A Phase 1 Study of Ruxolitinib, Steroids and Lenalidomide for Relapsed/Refractory Multiple Myeloma (RRMM) Patients
for Multiple Myeloma
5 locations incl. Alhambra
Sponsor: Oncotherapeutics
Sex: All·Age: 18+
Code: NCT03110822·Phase 1·Recruiting·Listed Apr 2017